These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3318899)

  • 1. Slow release aminophylline in long term management of chronic childhood asthma.
    Bose B; Haider SA
    Br J Clin Pract; 1987 Mar; 41(3):644-7. PubMed ID: 3318899
    [No Abstract]   [Full Text] [Related]  

  • 2. Subjective and objective changes noted by patients with bronchial asthma taking slow-release aminophylline.
    Nicholson EM; Laszlo G
    J Int Med Res; 1979; 7 Suppl 1():32-3. PubMed ID: 374161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of slow-release salbutamol with slow-release aminophylline in nocturnal asthma.
    Milledge JS; Morris J
    J Int Med Res; 1979; 7 Suppl 1():106-10. PubMed ID: 35430
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled trial of slow-release aminophylline in childhood asthma: are short-term trials valid?
    Wilson N; Silverman M
    Br Med J (Clin Res Ed); 1982 Mar; 284(6319):863-6. PubMed ID: 6802327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two aminophylline preparations in nocturnal asthma.
    Al-Khader A; Cole RB; Thompson D
    Br J Dis Chest; 1979 Apr; 73(2):169-72. PubMed ID: 394755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlling reversible bronchial obstruction using rapidly dissolving aminophylline (Syntophyllin) and slow-release aminophylline (Aminomal R)].
    Vondra V; Prazáková J; Reisová M
    Cas Lek Cesk; 1985 Nov; 124(44):1353-7. PubMed ID: 4064081
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of a controlled-release aminophylline tablet (Phyllocontin Continus) as a concomitant therapy in patients receiving salbutamol.
    Boyd G; Clark CJ
    J Int Med Res; 1979; 7 Suppl 1():34-5. PubMed ID: 374162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminophylline suppositories and sustained-release tablets compared in bronchospasm.
    Ross AE
    Practitioner; 1981 Jul; 225(1357):1061-2. PubMed ID: 7031630
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of serum theophylline levels with plain and slow-release aminophylline in patient with airway obstruction.
    Muittari A; Allonen H
    J Int Med Res; 1981; 9(5):378-80. PubMed ID: 7028535
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic asthma in children: comparison between a delayed-action theophylline preparation and a prompt-release aminophylline preparation].
    Longo G; Poli F; Strinati R; Longo F
    Pediatr Med Chir; 1984; 6(5):645-9. PubMed ID: 6535126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosage guidelines for slow-release aminophylline in childhood asthma.
    Blumenthal I; Berry D
    Br J Clin Pharmacol; 1980 May; 9(5):526-7. PubMed ID: 7397070
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of the effectiveness of aminophylline in treating bronchial asthma and spastic bronchitis].
    Chyrek-Borowska S; Szymański W; Niklińska B; Obrzut D; Michalska I
    Pol Tyg Lek; 1988 Oct 17-24; 43(42-43):1377-9. PubMed ID: 3075278
    [No Abstract]   [Full Text] [Related]  

  • 14. A double blind cross-over study of a slow release aminophylline tablet (Phyllocontin Continus tablets) as a concomitant therapy in patients with chronic bronchitis on salbutamol maintenance therapy.
    Black GS
    Br J Clin Pract; 1980 Jun; 34(6):175-7, 81. PubMed ID: 7002194
    [No Abstract]   [Full Text] [Related]  

  • 15. Safe and effective use of sustained-release and intravenous theophylline.
    Boggs PB
    Compr Ther; 1982 Mar; 8(3):17-21. PubMed ID: 7067393
    [No Abstract]   [Full Text] [Related]  

  • 16. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative subacute study of the effects and side effects of a non-depot theophylline preparation (Euspirax) and a depot preparation (Euphyllin retard)--a contribution to long-term therapy of asthma].
    Eitner L; Wettengel R; Schnitker J
    Prax Klin Pneumol; 1983 Jun; 37(6):236-42. PubMed ID: 6889277
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current role of oral theophylline derivatives in respiratory medicine: summary of symposium.
    Pride NB
    J Int Med Res; 1979; 7 Suppl 1():111-3. PubMed ID: 437304
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis.
    Jenkins PF; White JP; Jariwalla AJ; Anderson G; Campbell IA
    Br J Dis Chest; 1982 Jan; 76(1):57-60. PubMed ID: 7037034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.